The Distribution of Carbapenem-Resistant Acinetobacter Species and High Prevalence of CC92 OXA-23-Producing Acinetobacter Baumannii in Community Hospitals in South Korea

References

• Villers D, Espaze E, Coste-Burel M, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med. 1998;129(3):182–189. doi:10.7326/0003-4819-129-3-199808010-00003
   PubMed Web of Science ®Google Scholar
• Chen CT, Wang YC, Kuo SC, et al. Community-acquired bloodstream infections caused by Acinetobacter baumannii: a matched case-control study. J Microbiol Immunol Infect. 2018;51(5):629–635. doi:10.1016/j.jmii.2017.02.004
   PubMedGoogle Scholar
• Li J, Li Y, Cao X, et al. Genome-wide identification and oxacillinase OXA distribution characteristics of Acinetobacter spp. based on a global database. Front Microbiol. 2023;14:1174200. doi:10.3389/fmicb.2023.1174200
   PubMed Web of Science ®Google Scholar
• Qin J, Feng Y, Lü X, et al. Precise Species Identification for Acinetobacter: a genome-based study with description of two novel Acinetobacter species. mSystems. 2021;6(3):e0023721. doi:10.1128/mSystems.00237-21
   PubMed Web of Science ®Google Scholar
• Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939–951. doi:10.1038/nrmicro1789
   PubMed Web of Science ®Google Scholar
• Yoon EJ, Kim JO, Yang JW, et al. The blaOXA-23-associated transposons in the genome of Acinetobacter spp. represent an epidemiological situation of the species encountering carbapenems. J Antimicrob Chemother. 2017;72(10):2708–2714. doi:10.1093/jac/dkx205
   PubMed Web of Science ®Google Scholar
• Scaife W, Young HK, Paton RH, et al. Transferable imipenem-resistance in Acinetobacter species from a clinical source. J Antimicrob Chemother. 1995;36(3):585–586. doi:10.1093/jac/36.3.585
   PubMed Web of Science ®Google Scholar
• Castanheira M, Mendes RE, Gales AC. Global epidemiology and mechanisms of resistance of Acinetobacter baumannii-calcoaceticus Complex. Clin Infect Dis. 2023;76(Suppl 2):S166–S178. doi:10.1093/cid/ciad109
   PubMedGoogle Scholar
• Kim DH, Choi JY, Kim HW, et al. Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands. Antimicrob Agents Chemother. 2013;57(11):5239–5246. doi:10.1128/AAC.00633-13
   PubMed Web of Science ®Google Scholar
• Lee H, Yoon EJ, Kim D, et al. Antimicrobial resistance of major clinical pathogens in South Korea, May 2016 to April 2017: first one-year report from Kor-GLASS. Euro Surveill. 2018;23(42):1800047. doi:10.2807/1560-7917.ES.2018.23.42.1800047
   PubMedGoogle Scholar
• Kim D, Yoon EJ, Hong JS, et al. Major bloodstream infection-causing bacterial pathogens and their antimicrobial resistance in South Korea, 2017–2019: Phase I Report From Kor-GLASS. Front Microbiol. 2022;12:799084. doi:10.3389/fmicb.2021.799084
   PubMed Web of Science ®Google Scholar
• Bartual SG, Seifert H, Hippler C, et al. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005;43(9):4382–4390. doi:10.1128/JCM.43.9.4382-4390.2005
   PubMed Web of Science ®Google Scholar
• Feil EJ, Li BC, Aanensen DM, et al. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol. 2004;186(5):1518–1530. doi:10.1128/JB.186.5.1518-1530.2004
   PubMed Web of Science ®Google Scholar
• Nocera FP, Attili AR, De Martino L. Acinetobacter baumannii: its clinical significance in human and veterinary medicine. Pathogens. 2021;10(2):127. doi:10.3390/pathogens10020127
   PubMed Web of Science ®Google Scholar
• Manchanda V, Sanchaita S, Singh N. Multidrug resistant Acinetobacter. J Glob Infect Dis. 2010;2(3):291–304. doi:10.4103/0974-777X.68538
   PubMedGoogle Scholar
• Ruan Z, Chen Y, Jiang Y, et al. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int J Antimicrob Agents. 2013;42(4):322–328. doi:10.1016/j.ijantimicag.2013.06.019
   PubMed Web of Science ®Google Scholar
• Huang L, Sun L, Yan Y. Clonal spread of carbapenem resistant Acinetobacter baumannii ST92 in a Chinese hospital during a 6-year period. J Microbiol. 2013;51(1):113–117. doi:10.1007/s12275-013-2341-4
   PubMed Web of Science ®Google Scholar
• Nguyen M, Joshi SG. Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review. J Appl Microbiol. 2021;131(6):2715–2738. doi:10.1111/jam.15130
   PubMed Web of Science ®Google Scholar
• Higgins PG, Dammhayn C, Hackel M, et al. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2010;65(2):233–238. doi:10.1093/jac/dkp428
   PubMed Web of Science ®Google Scholar
• Zarrilli R, Pournaras S, Giannouli M, et al. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents. 2013;41(1):11–19. doi:10.1016/j.ijantimicag.2012.09.008
   PubMed Web of Science ®Google Scholar
• Lee Y, Lee J, Jeong SH, et al. Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene. J Antimicrob Chemother. 2011;66(1):66–72. doi:10.1093/jac/dkq402
   PubMed Web of Science ®Google Scholar
• Kang HM, Yun KW, Choi EH. Molecular epidemiology of Acinetobacter baumannii complex causing invasive infections in Korean children during 2001–2020. Ann Clin Microbiol Antimicrob. 2023;22(1):32. doi:10.1186/s12941-023-00581-3
   PubMed Web of Science ®Google Scholar
• Jeon H, Kim S, Kim MH, et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates from a Korean hospital that carry blaOXA-23. Infect Genet Evol. 2018;58:232–236. doi:10.1016/j.meegid.2018.01.003
   PubMed Web of Science ®Google Scholar
• Jun SH, Lee DE, Hwang HR, et al. Clonal change of carbapenem-resistant Acinetobacter baumannii isolates in a Korean hospital. Infect Genet Evol. 2021;93:104935. doi:10.1016/j.meegid.2021.104935
   PubMed Web of Science ®Google Scholar
• Shenkutie AM, Yao MZ, Siu GK, et al. Biofilm-induced antibiotic resistance in clinical Acinetobacter baumannii Isolates. Antibiotics. 2020;9(11):817. doi:10.3390/antibiotics9110817
   Google Scholar
• Kim MH, Jeong H, Sim YM, et al. Using comparative genomics to understand molecular features of carbapenem-resistant Acinetobacter baumannii from South Korea causing invasive infections and their clinical implications. PLoS One. 2020;15(2):e0229416. doi:10.1371/journal.pone.0229416
   PubMed Web of Science ®Google Scholar
• Bagudo AI, Obande GA, Harun A, et al. Advances in automated techniques to identify Acinetobacter calcoaceticus-Acinetobacter baumannii complex. Asian Biomed. 2020;14(5):177–186. doi:10.1515/abm-2020-0026
   Web of Science ®Google Scholar
• Nemec A, Radolfova-Krizova L, Maixnerova M, et al. Taxonomy of haemolytic and/or proteolytic strains of the genus Acinetobacter with the proposal of Acinetobacter courvalinii sp. nov. (genomic species 14 sensu Bouvet & Jeanjean), Acinetobacter dispersus sp. nov. (genomic species 17), Acinetobacter modestus sp. nov. Acinetobacter proteolyticus sp. nov. and Acinetobacter vivianii sp. Nov. Int J Syst Evol Microbiol. 2016;66(4):1673–1685. doi:10.1099/ijsem.0.000932
   PubMedGoogle Scholar
• Ejaz H, Qamar MU, Junaid K, et al. The molecular detection of class b and class d carbapenemases in clinical strains of Acinetobacter calcoaceticus-baumannii Complex: the high burden of antibiotic resistance and the co-existence of carbapenemase genes. Antibiotics. 2022;11(9):1168. doi:10.3390/antibiotics11091168
   Google Scholar
• López C, Ayala JA, Bonomo RA, et al. Protein determinants of dissemination and host specificity of metallo-β-lactamases. Nat Commun. 2019;10(1):3617. doi:10.1038/s41467-019-11615-w
   PubMedGoogle Scholar